Cadila Pharmaceuticals announces World’s First – Aqueous Vitamin D Injection

Gandhinagar: Cadila Pharmaceuticals today announced the launch of the world’s first aqueous formulation of cholecalciferol, for the treatment of Vitamin D deficiency. It has been developed through totally indigenous research.

The company said its aqueous cholecalciferol injection offers a solution with rapid correction of Vitamin D deficiency in short span of time, and enhances the efficacy of treatment by ensuring painless process.

Key Features of Cadila Pharmaceuticals has announced about its Aqueous Cholecalciferol Injection:

Pharmacokinetics and Pharmacodynamics: Aqueous formulation demonstrates significant improvements in both pharmacokinetic and pharmacodynamics properties of the drug , compared to conventional oil-based cholecalciferol preparations.

Correction of Vitamin D Deficiency: Patients can benefit from a correction of Vitamin D deficiency in short span of time, addressing a critical need for expedited treatment outcomes in many major illnesses.

Painless Administration: The injection is designed for ease of use, providing a painless experience for patients, promoting better compliance with treatment regimens.

The significance of Vitamin D extends well beyond bone health, influencing outcomes in various conditions such as Cardiovascular Disease, Diabetes Mellitus, and weakened immune systems. Vitamin D acts as an anti-hypertrophic agent, a stimulator of vascular smooth muscle cell proliferation, anti- fibrotic, antioxidant, anti-inflammatory, and an inhibitor of the Renin-Angiotensin-Aldosterone System (RAAS).

Dr. Rajiv I. Modi, Chairman and Managing Director, Cadila Pharmaceuticals, stated, “Our commitment to innovation and patient centric research to bridge the gap in areas of unmet medical need has driven the development of this injection.,”

Dr. Vijayesh Gupta , COO- BSBU, Cadila Pharmaceuticals, added, “We anticipate this innovation will help clinicians to better design their treatment protocols for Vitamin D deficient patients and a large number of patients will benefit from the next generation, world’s first aqueous injectable Vitamin D.”